Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7458)
All Articles published online
|
Apr 14, 2012 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Naing C, Mak JW, Ahmed SI, Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis. World J Gastroenterol 2012; 18(14): 1642-1651 [PMID: 22529694 DOI: 10.3748/wjg.v18.i14.1642] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i14/1642.htm |
| Number | Citing Articles |
| 1 |
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysis. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-0976-x
|
| 2 |
Bouharati Khaoula, Bouharati Imene, Guenifi Wahiba, Gasmi Abdelkader, Laouamri Slimane. Intelligent Analysis of Some Factors Accompanying Hepatitis B. MOLECULAR SCIENCES AND APPLICATIONS 2022; 2: 61 doi: 10.37394/232023.2022.2.7
|
| 3 |
Yujin Ding, Guangdi Li, Zhiguang Zhou, Tuo Deng. Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism 2021; 121: 154802 doi: 10.1016/j.metabol.2021.154802
|
| 4 |
Man-Huei Chang, Gloria L. Beckles, Ramal Moonesinghe, Benedict I. Truman. County-Level Socioeconomic Disparities in Use of Medical Services for Management of Infections by Medicare Beneficiaries With Diabetes—United States, 2012. Journal of Public Health Management and Practice 2019; 25(4): E44 doi: 10.1097/PHH.0000000000000800
|
| 5 |
Dalia E. Desouky, Zaynab Kasemy, Alaa E. Abdel-Hamid, Mohamed S. Omar. Insulin Resistance and Prediabetes in Hepatitis C Virus Patients. The American Journal of the Medical Sciences 2015; 350(2): 77 doi: 10.1097/MAJ.0000000000000513
|
| 6 |
Lawrence Serfaty. Metabolic Manifestations of Hepatitis C Virus. Clinics in Liver Disease 2017; 21(3): 475 doi: 10.1016/j.cld.2017.03.004
|
| 7 |
Mahmoud Abdo, Ahmed Rabiee, Zeinab Abdellatif, Shereen Abdel Alem, Ahmed Moustafa. Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir. European Journal of Gastroenterology & Hepatology 2021; 33(12): 1588 doi: 10.1097/MEG.0000000000001903
|
| 8 |
Cliviany Borges da Silva, Diego Alves Vieira, Luisa Freitas de Melo, Anna Luiza Soares Chagas, Adriana Dias Gomes, César Lúcio Lopes de Faria Jr, Rosângela Teixeira, Dulciene Maria de Magalhães Queiroz, Gifone Aguiar Rocha, Maria Marta Sarquis Soares, Juliana Maria Trindade Bezerra, Luciana Diniz Silva. Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus. World Journal of Hepatology 2020; 12(4): 137-148 doi: 10.4254/wjh.v12.i4.137
|
| 9 |
Bahawal Sana, Abdul Manan, Huma Khan, Muhammad Amjad Bashir, Muhammad Shahid Nisar, Khizer Samiullah, Irum Aziz, Muhammad Farooq, Asma Noreen, Talat Bilal Yasoob, Afrah Fahad Alkhuriji, Nawal M. Al-Malahi, Abdulrahman Alasmari, Mohammed Ali Alshehri, Munaza Batool, Awais Amjad, Sagheer Atta. A demographic study on causes of hepatitis transitions among the agricultural community. Journal of King Saud University - Science 2022; 34(5): 102085 doi: 10.1016/j.jksus.2022.102085
|
| 10 |
Mohammed J. Saeed, Margaret A. Olsen, William G. Powderly, Rachel M. Presti. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients. Journal of Clinical Gastroenterology 2017; 51(1): 70 doi: 10.1097/MCG.0000000000000566
|
| 11 |
Giacomo Gastaldi, Nicolas Goossens, Sophie Clément, Francesco Negro. Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review. Journal of Advanced Research 2017; 8(2): 149 doi: 10.1016/j.jare.2016.11.003
|
| 12 |
Raghda N. Marzaban, Hesham I. AlMekhzangy, Wafaa ElAkel, Tamer M ElBaz, Yehia M. ElShazly, Kadry ElSaeed, Mahmoud Anees, Mohamed Said, Magdy A. ElSerafy, Gamal G. Esmat, Wahid H. Doss. Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapy. Arab Journal of Gastroenterology 2024; doi: 10.1016/j.ajg.2023.12.006
|
| 13 |
Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto. Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?. Biomedicines 2022; 10(3): 534 doi: 10.3390/biomedicines10030534
|
| 14 |
Palaniappan Manickam, Estela Mogrovejo, Rajesh Krishnamoorthi. HIV/Hepatitis C Virus-Coinfected Patients: Is There a Better Marker for Atherogenicity?. AIDS Research and Human Retroviruses 2013; 29(5): 745 doi: 10.1089/aid.2012.0366
|
| 15 |
Cho Naing, Joon Wah Mak, Nyunt Wai, Mala Maung. Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?. Current Diabetes Reports 2013; 13(3): 428 doi: 10.1007/s11892-013-0370-3
|
| 16 |
Eva M. Teegen, Michael Dürr, Max M. Maurer, Franziska Eurich, Antonia Vollbort, Brigitta Globke, Marcus Bahra, Hendrik Blaeker, Johann Pratschke, Dennis Eurich. Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct‐acting antivirals: Therapy of HCV‐recurrence. Transplant Infectious Disease 2019; 21(1) doi: 10.1111/tid.13020
|
| 17 |
Livia Melo Villar, Bruno Geloneze, Ana Carolina Junqueira Vasques, Maria Lucia Elias Pires, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Vanessa Alves Marques, Leticia de Paula Scalioni, Elisabeth Lampe, Motoyuki Otsuka. Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals. PLOS ONE 2019; 14(2): e0211193 doi: 10.1371/journal.pone.0211193
|
| 18 |
Marian-Sorin Popescu, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Radu Mitruț, Andreea Letitia Arsene, Dragoș Nicolae Mărgăritescu, Daniela Calina, Anca Oana Docea, Paul Mitruț. Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection. Biomedicines 2022; 10(9): 2093 doi: 10.3390/biomedicines10092093
|
| 19 |
Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, Asif Ali Burney. Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study. Journal of Diabetes Research 2013; 2013: 1 doi: 10.1155/2013/539361
|
| 20 |
James A. Ndako, Akinyomade O. Owolabi, Joseph A. Olisa, Jeremiah A. Akinwumi, Victor T. Dojumo, Oludolapo Olatinsu, Blessing A. Adebayo. Studies on the prevalence of Hepatitis C virus infection in diabetic patients attending a tertiary health-care facility South-west Nigeria. BMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-020-05388-7
|
| 21 |
Prashant Pandya, Chaitanya Pant, Ryan Taylor, Olurinde Oni. Impact of Sustained Virological Response to Chronic Hepatitic C Antiviral Therapy on New Onset Diabetes Mellitus Type 2 after Controlling for Metabolic Syndrome. Journal of Investigative Medicine 2017; 65(4): 765 doi: 10.1136/jim-2016-000343
|
| 22 |
Ying Chen, Hanzhen Ji, Jianguo Shao, Yulong Jia, Qi Bao, Jianan Zhu, Lei Zhang, Yi Shen. Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis. Digestive Diseases and Sciences 2020; 65(7): 1940 doi: 10.1007/s10620-019-05918-7
|
| 23 |
L Montenegro, A De Michina, G Misciagna, V Guerra, A Di Leo. Virus C Hepatitis and Type 2 Diabetes: A Cohort Study in Southern Italy. American Journal of Gastroenterology 2013; 108(7): 1108 doi: 10.1038/ajg.2013.90
|
| 24 |
W-P Koh, R Wang, A Jin, M C Yu, J-M Yuan. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. British Journal of Cancer 2013; 108(5): 1182 doi: 10.1038/bjc.2013.25
|
| 25 |
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
|
| 26 |
Huseyin Korkmaz, Recep Kesli, Barıs Onder Pamuk, Suleyman Hilmi Ipekci, Yuksel Terzi, Levent Kebapcilar. Assessment of Evidence for Positive Association and Seroprevalence of Hepatitis B and C in Diabetic Patients in a Developing Country. Journal of Investigative Medicine 2015; 63(2): 251 doi: 10.1097/JIM.0000000000000126
|
| 27 |
|
| 28 |
C. Schnier, S. Wild, Z. Kurdi, C. Povey, D. J. Goldberg, S. J. Hutchinson. Matched population‐based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infection. Journal of Viral Hepatitis 2016; 23(8): 596 doi: 10.1111/jvh.12520
|
| 29 |
Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun. Prevalence of and Factors Influencing Impaired Glucose Tolerance Among Hepatitis B Carriers. Medicine 2014; 93(20): e91 doi: 10.1097/MD.0000000000000091
|
| 30 |
Ting‐Shuo Huang, Chih‐Lang Lin, Mu‐Jie Lu, Chau‐Ting Yeh, Kung‐Hao Liang, Chi‐Chin Sun, Yu‐Chiau Shyu, Rong‐Nan Chien. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C‐infected patients: A population‐based cohort study. Journal of Gastroenterology and Hepatology 2017; 32(7): 1355 doi: 10.1111/jgh.13670
|
| 31 |
Nicolas Goossens, Francesco Negro. Cardiovascular Manifestations of Hepatitis C Virus. Clinics in Liver Disease 2017; 21(3): 465 doi: 10.1016/j.cld.2017.03.003
|
| 32 |
Yannick Chibinda Birato, Tony Akilimali Shindano, Daudi Cinyabuuma, Ciza Abel, Cikomola Justin Chiruza, Andre N. H. Bulabula. Seroprevalence and associated risk factors of hepatitis C infection among diabetic patients in South‐Kivu, Eastern Democratic Republic of the Congo: A cross‐sectional study. Health Science Reports 2023; 6(8) doi: 10.1002/hsr2.1504
|
| 33 |
Milind Y. Junghare, Hassan N. Ibrahim. Chronic Renal Disease. 2015; : 544 doi: 10.1016/B978-0-12-411602-3.00045-7
|
| 34 |
Tsutomu Nishida. Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance Test. Journal of the Endocrine Society 2017; 1(7): 886 doi: 10.1210/js.2017-00183
|
| 35 |
Z. Younossi, M. Stepanova, S. Saab, G. Trimble, A. Mishra, L. Henry. The association of hepatitis C virus infection and post‐liver transplant diabetes: data from 17 000 HCV‐infected transplant recipients. Alimentary Pharmacology & Therapeutics 2015; 41(2): 209 doi: 10.1111/apt.13027
|
| 36 |
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in Iran. World Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
|
| 37 |
|
| 38 |
Man Yuan, Juan Zhou, Lingyao Du, Libo Yan, Hong Tang. Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58786-x
|
| 39 |
|
| 40 |
Roaid Khan, Graham R. Foster, Tahseen A. Chowdhury. Managing Diabetes in Patients with Chronic Liver Disease. Postgraduate Medicine 2012; 124(4): 130 doi: 10.3810/pgm.2012.07.2574
|
| 41 |
Chang Hwi Yoon, Young-Joo Jin, Jin Woo Lee. Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area. European Journal of Gastroenterology & Hepatology 2018; 30(9): 1090 doi: 10.1097/MEG.0000000000001174
|
| 42 |
Khalid Siddiqui, Shivani Tyagi. Genetics, genomics and personalized medicine in Type 2 diabetes: a perspective on the Arab region. Personalized Medicine 2015; 12(4): 417 doi: 10.2217/pme.15.11
|
| 43 |
Luis Calzadilla-Bertot, Eduardo Vilar-Gomez, Ana Torres-Gonzalez, Maray Socias-Lopez, Moises Diago, Leon A. Adams, Manuel Romero-Gomez. Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis. Digestive and Liver Disease 2016; 48(3): 283 doi: 10.1016/j.dld.2015.12.002
|
| 44 |
Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Michael B. Davidson, Daniel Einhorn, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael H. Davidson. American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement. Endocrine Practice 2013; 19: 1 doi: 10.4158/EP13176.CSUPPL
|
| 45 |
Syed Haris Ahmed, Kathryn Biddle, Titus Augustine, Shazli Azmi. Post-Transplantation Diabetes Mellitus. Diabetes Therapy 2020; 11(4): 779 doi: 10.1007/s13300-020-00790-5
|
| 46 |
Mohamad S. Hakim, Xinying Zhou, Yijin Wang, Maikel P. Peppelenbosch, Qiuwei Pan. Anti-diabetic drugs, insulin and metformin, have no direct interaction with hepatitis C virus infection or anti-viral interferon response. AIMS Molecular Science 2014; 1(1): 49 doi: 10.3934/molsci.2014.1.49
|
| 47 |
Diego F. Cuadros, F. DeWolfe Miller, Nico Nagelkerke, Laith J. Abu-Raddad. Association between HCV infection and diabetes type 2 in Egypt: is it time to split up?. Annals of Epidemiology 2015; 25(12): 918 doi: 10.1016/j.annepidem.2015.09.005
|
| 48 |
CUIXIA CAI, JUN ZENG, HUIHUI WU, RONG SHI, MIN WEI, YUAN GAO, WENLI MA. Association between hepatitis B virus infection and diabetes mellitus: A meta-analysis. Experimental and Therapeutic Medicine 2015; 10(2): 693 doi: 10.3892/etm.2015.2537
|
| 49 |
Shereen Abdel Alem, Aisha Elsharkawy, Rabab Fouad, Eman Adel, Zeinab Abdellatif, Sherief Musa, Ahmed Nagy, Muhammad S. Hussein, Ayman Yosry, Gamal Esmat. Improvement of glycemic state among responders to Sofosbuvir‐based treatment regimens: Single center experience. Journal of Medical Virology 2017; 89(12): 2181 doi: 10.1002/jmv.24897
|
| 50 |
Kenneth Cusi. The relationship between hepatitis C virus infection and diabetes: Time for a divorce?. Hepatology 2014; 60(4): 1121 doi: 10.1002/hep.27252
|
| 51 |
Olufunso O. Sogbanmu, Larry O. Obi, Daniel T. Goon, Anthony Okoh, Benson Iweriebor, Uchechukwu. U. Nwodo, Anthony I. Ajayi, Tennison O. Digban. Diagnosing Diabetes Mellitus With Glycated Haemoglobin in Newly Diagnosed HIV-positive Patients in Buffalo City Municipality, South Africa: A Cross-sectional Study. The Open Public Health Journal 2019; 12(1): 263 doi: 10.2174/1874944501912010263
|
| 52 |
Rudruidee Karnchanasorn, Horng-Yih Ou, James Lin, Lee-Ming Chuang, Ken C. Chiu. Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination. Current Diabetes Reports 2016; 16(10) doi: 10.1007/s11892-016-0790-y
|
| 53 |
Debaka Belete, Dessie Kassaw, Tesfaye Andualem, Quirino Lai. Prevalence of Hepatitis B and Hepatitis C Viral Infections and Their Associated Factors among Diabetic Patients Visiting Debre Tabor Referral Hospital, Northwest Ethiopia, 2021: A Cross-Sectional Study. Canadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/5077706
|
| 54 |
Muneerah Hamad Aldubaie, Prarthana M. Suryavamshi, Uma M. Irfan, Hamad A. Al-Hamed, Turki Abdullah Almogbel, Ahmad Almatroudi, Faris Alrumaihi, Khaled Allemailem. Prevalence of Hepatitis C Viral Infection among Diabetes Mellitus Patients in Qassim Region, Saudi Arabia. Journal of Pure and Applied Microbiology 2023; 17(3): 1722 doi: 10.22207/JPAM.17.3.37
|
| 55 |
V. V. Tsvetkov, I. I. Tokin, S. A. Pozdnjakova. Clinical epidemiology of extrahepatic manifestations of chronic hepatitis C virus infection. Medical Council 2020; (21): 248 doi: 10.21518/2079-701X-2019-21-248-253
|
| 56 |
Misbah Ul Qamar, Maria Gill, Faiza Ikram, Shaheena Naz, Hina Sadaf, Zobiah Hafeez. Insulin Resistance and Chronic Hepatitis C: Relationship With Serum Iron and Hepcidin. Cureus 2020; doi: 10.7759/cureus.12349
|
| 57 |
Felix M. Wensveen, Marko Šestan, Tamara Turk Wensveen, Bojan Polić. ‘Beauty and the beast’ in infection: How immune–endocrine interactions regulate systemic metabolism in the context of infection. European Journal of Immunology 2019; 49(7): 982 doi: 10.1002/eji.201847895
|
| 58 |
Wangjun Zhang, Fan Xiao, Jie Li, Xiaoyu Guo, Zhitao Lin, Zijian Huang, Ning Mao, Bei Sun, Gang Wang. Rare heterochronous liver and pancreatic multiple primary cancers: a case report and literature review. Zeitschrift für Gastroenterologie 2020; 58(11): 1094 doi: 10.1055/a-1160-6082
|
| 59 |
Praveen Raman Mishra, Akash Bharti, Ridhi Arora, Irfan Ahmad Mir, V. P. S. Punia. Increased Insulin Resistance in Hepatitis-C Infection—Association with Altered Hepatic Function Testing. Pathophysiology 2022; 29(3): 326 doi: 10.3390/pathophysiology29030024
|
| 60 |
P. Pavone, T. Tieghi, G. d'Ettorre, M. Lichtner, R. Marocco, I. Mezzaroma, G. Passavanti, P. Vittozzi, C.M. Mastroianni, V. Vullo. Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents. Clinical Microbiology and Infection 2016; 22(5): 462.e1 doi: 10.1016/j.cmi.2015.12.030
|
| 61 |
Yun Soo Hong, Yoosoo Chang, Seungho Ryu, Miguel Cainzos-Achirica, Min-Jung Kwon, Yiyi Zhang, Yuni Choi, Jiin Ahn, Sanjay Rampal, Di Zhao, Roberto Pastor-Barriuso, Mariana Lazo, Hocheol Shin, Juhee Cho, Eliseo Guallar. Hepatitis B and C virus infection and diabetes mellitus: A cohort study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04206-6
|
| 62 |
Alessia Ciancio, Roberta Bosio, Simona Bo, Marianna Pellegrini, Marco Sacco, Edoardo Vogliotti, Giulia Fassio, Andrea G. F. Bianco Mauthe Degerfeld, Monica Gallo, Chiara Giordanino, Lodovico Terzi di Bergamo, Davide Ribaldone, Elisabetta Bugianesi, Antonina Smedile, Mario Rizzetto, Giorgio Maria Saracco. Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct‐acting antiviral agents. Journal of Medical Virology 2018; 90(2): 320 doi: 10.1002/jmv.24954
|
| 63 |
Alessia Ciancio, Davide G. Ribaldone, Anna Dotta, Chiara Giordanino, Marco Sacco, Sharmila Fagoonee, Rinaldo Pellicano, Giorgio M. Saracco. Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C successfully treated with direct‐acting antiviral agents. Liver International 2021; 41(2): 276 doi: 10.1111/liv.14676
|
| 64 |
Jun Lu, Xuhong Hou, Hong Tu, Zhenghao Tang, Yongbing Xiang, Yuqian Bao, Jianren Gu, Weiping Jia. Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes. Journal of Diabetes Investigation 2017; 8(4): 619 doi: 10.1111/jdi.12609
|
| 65 |
Giorgio A. Roccaro, Robert Mitrani, Wei‐Ting Hwang, Kimberly A. Forde, K. Rajender Reddy. Sustained Virological Response Is Associated with a Decreased Risk of Posttransplant Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C–Related Liver Disease. Liver Transplantation 2018; 24(12): 1665 doi: 10.1002/lt.25351
|
| 66 |
Silvia Fabiani, Poupak Fallahi, Silvia Martina Ferrari, Mario Miccoli, Alessandro Antonelli. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. Reviews in Endocrine and Metabolic Disorders 2018; 19(4): 405 doi: 10.1007/s11154-017-9440-1
|
| 67 |
Cesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, Dario Roccatello, Gabriele Pozzato, Riccardo Nevola, Maurizio Tonizzo, Stefano Gitto, Pietro Andreone, Valter Gattei. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy. Viruses 2021; 13(11): 2249 doi: 10.3390/v13112249
|
| 68 |
Derong Sun, Wenqian Qi, Song Wang, Xu Wang, Yonggui Zhang, Jiangbin Wang. Genetic Polymorphism of CYP27B1-1260 as Associated With Impaired Fasting Glucose in Patients With Chronic Hepatitis C Undergoing Antiviral Therapy. Hepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.35179
|
| 69 |
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
|
| 70 |
Roy Hall, Leigh Owens, Brenda Govan, Marie Caltabiano, Paula Clancy, Alanna Sorenson, Yvonne Cadet-James. The Impact of Prior Flavivirus Infections on the Development of Type 2 Diabetes Among the Indigenous Australians. The American Journal of Tropical Medicine and Hygiene 2016; 95(2): 265 doi: 10.4269/ajtmh.15-0727
|
| 71 |
Trevor A. Crowell, Kelly A. Gebo, Ashwin Balagopal, John A. Fleishman, Allison L. Agwu, Stephen A. Berry. Impact of Hepatitis Coinfection on Hospitalization Rates and Causes in a Multicenter Cohort of Persons Living With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 2014; 65(4): 429 doi: 10.1097/QAI.0000000000000059
|
| 72 |
Eric Lontchi-Yimagou, Charly Feutseu, Sebastien Kenmoe, Alexandra Lindsey Djomkam Zune, Solange Fai Kinyuy Ekali, Jean Louis Nguewa, Siméon Pierre Choukem, Jean Claude Mbanya, Jean Francois Gautier, Eugene Sobngwi. Non-autoimmune diabetes mellitus and the risk of virus infections: a systematic review and meta-analysis of case-control and cohort studies. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88598-6
|
| 73 |
Clarissa Cordeiro Alves Arrelias, Fernando Belissimo Rodrigues, Maria Teresa da Costa Gonçalves Torquato, Carla Regina de Souza Teixeira, Flávia Fernanda Luchetti Rodrigues, Maria Lucia Zanetti. Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitus. Revista Latino-Americana de Enfermagem 2018; 26(0) doi: 10.1590/1518-8345.2774.3085
|
| 74 |
Jing Liang, Chaoyang Lv, Minling Chen, Ming Xu, Chenhe Zhao, Yinqiu Yang, Jina Wang, Dong Zhu, Jian Gao, Ruiming Rong, Tongyu Zhu, Mingxiang Yu. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantation. Journal of Diabetes 2019; 11(5): 370 doi: 10.1111/1753-0407.12853
|
| 75 |
Vijay Shivaswamy, Brian Boerner, Jennifer Larsen. Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes. Endocrine Reviews 2016; 37(1): 37 doi: 10.1210/er.2015-1084
|
| 76 |
Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis. Acta Diabetologica 2019; 56(3): 341 doi: 10.1007/s00592-018-1257-1
|
| 77 |
Naim Abu Freha, Tamar Wainstock, Tzvi Najman Menachem, Eyal Sheiner. Maternal Hepatitis B Virus or Hepatitis C Virus Carrier Status and Long-Term Endocrine Morbidity of the Offspring—A Population-Based Cohort Study. Journal of Clinical Medicine 2020; 9(3): 796 doi: 10.3390/jcm9030796
|
| 78 |
Shazia Hussain, Tahseen A. Chowdhury. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus. Drugs 2019; 79(3): 231 doi: 10.1007/s40265-019-1061-4
|
| 79 |
Gautam Das, Hemanth Bolusani. Hepatitis C virus infection and diabetes. Practical Diabetes 2016; 33(4): 123 doi: 10.1002/pdi.2017
|
| 80 |
Yu-Cheng Cheng, Teng-Yu Lee, Yu-Hsuan Li, Chin-Li Lu, Hsiu-Chen Liu, Meei Ling Sheu, I-Te Lee. Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55352-7
|
| 81 |
P. A. Beliy, K. R. Dudina, O. O. Znoyko, T. N. Markova, I. A. Morozova, N. P. Blokhina, E. A. Nurmukhametova, N. D. Yushchuk. Prevalence of chronic HCV infection in patients with type 2 diabetes mellitus in Russia. Diabetes mellitus 2022; 25(1): 4 doi: 10.14341/DM12847
|
| 82 |
Elham Sayed Marei, Hanan Mohamed Gabr, Dina Sami Shaheen. Potential role of vaspin and apelin in chronic hepatitis C virus patients with and without diabetes. Journal of Radiation Research and Applied Sciences 2020; 13(1): 155 doi: 10.1080/16878507.2020.1715556
|
| 83 |
Davis Kibirige, Richard Ssekitoleko, Edrisa Mutebi, William Worodria. Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: a cross sectional study. BMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-122
|
| 84 |
Taiba Zornitzki, Stephen Malnick, Lyudmila Lysyy, Hilla Knobler. Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World Journal of Gastroenterology 2015; 21(1): 233-239 doi: 10.3748/wjg.v21.i1.233
|
| 85 |
Simone Lanini, Paola Scognamiglio, Raffaella Pisapia, Claudia Minosse, Alessandro Agresta, Giuseppe Ippolito. Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy. International Journal of Antimicrobial Agents 2019; 53(5): 559 doi: 10.1016/j.ijantimicag.2018.11.024
|
| 86 |
R. Mahajan, J. Xing, S. J. Liu, K. N. Ly, A. C. Moorman, L. Rupp, F. Xu, S. D. Holmberg, S. D. Holmberg, E. H. Teshale, P. R. Spradling, A. C. Moorman, S. C. Gordon, D. R. Nerenz, M. Lu, L. Lamerato, L. B. Rupp, N. Akkerman, N. Oja-Tebbe, C. M. Cogan, D. Larkin, J. A. Boscarino, Z. S. Daar, J. B. Leader, R. E. Smith, C. C. Nakasato, V. Vijayadeva, K. E. Sylva, J. V. Parker, M. M. Schmidt, M. A. Schmidt, J. L. Donald, E. M. Keast. Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010. Clinical Infectious Diseases 2014; 58(8): 1055 doi: 10.1093/cid/ciu077
|
| 87 |
Julia M. Grottenthaler, Judith K. Füger, Moritz Mahling, Alfred Königsrainer, Nisar P. Malek, Andreas L. Birkenfeld, Silvio Nadalin, Christoph P. Berg, Nils Heyne, Martina Guthoff. Dynamics of glucose metabolism after liver transplantation: prediabetes as a window of opportunity for patient survival and long‐term kidney function. Transplant International 2021; 34(10): 1959 doi: 10.1111/tri.13967
|
| 88 |
Trevor A. Crowell, Stephen A. Berry, John A. Fleishman, Richard W. LaRue, Philip T. Korthuis, Ank E. Nijhawan, Richard D. Moore, Kelly A. Gebo. Impact of Hepatitis Coinfection on Healthcare Utilization Among Persons Living With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 2015; 68(4): 425 doi: 10.1097/QAI.0000000000000490
|
| 89 |
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal. Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4. Diabetes & Metabolism Journal 2017; 41(4): 316 doi: 10.4093/dmj.2017.41.4.316
|
| 90 |
Akira Matsumori. Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light Chains. Biomedicines 2022; 10(3): 666 doi: 10.3390/biomedicines10030666
|
| 91 |
Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI, Luigi E. ADINOLFI. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and management. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07129-3
|
| 92 |
Davide Giuseppe Ribaldone, Marco Sacco, Giorgio Maria Saracco. The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm. Journal of Clinical Medicine 2020; 9(2): 563 doi: 10.3390/jcm9020563
|
| 93 |
Elenjickal Elias John, Sudhir Mehta, Preet Mohinder Sohal, Jasvinder Singh Sandhu. Predictors of Short-Term Outcomes in Living Donor Renal Allograft Recipients: A Prospective Study From a Tertiary Care Center in North India. Cureus 2022; doi: 10.7759/cureus.28335
|
| 94 |
M. Hecking, J. Werzowa, M. Haidinger, W. H. Horl, J. Pascual, K. Budde, F. L. Luan, A. Ojo, A. P. J. de Vries, E. Porrini, G. Pacini, F. K. Port, A. Sharif, M. D. Saemann. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrology Dialysis Transplantation 2013; 28(3): 550 doi: 10.1093/ndt/gfs583
|
| 95 |
Jian Zhang, Yi Shen, Hui Cai, Yan‐Mei Liu, Gang Qin. Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta‐analysis. Hepatology Research 2015; 45(11): 1100 doi: 10.1111/hepr.12481
|
| 96 |
James Yue Zhang, Curtis Cooper, Mary-Anne Doyle. Association between hepatitis C antiviral treatment and diabetes mellitus: A case series. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(2): 104 doi: 10.3138/jammi-2019-0007
|
| 97 |
Samia T. Ali, Nagwa A. Mohamed. Inadequate serum hepcidin levels in chronic hepatitis C infection-induced type 2 diabetes mellitus. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(1): 91 doi: 10.4103/sjamf.sjamf_59_18
|
| 98 |
Constance E. Ruhl, Andy Menke, Catherine C. Cowie, James E. Everhart. Relationship of hepatitis C virus infection with diabetes in the U.S. population. Hepatology 2014; 60(4): 1139 doi: 10.1002/hep.27047
|
| 99 |
Shilpa Lingala, Marc G. Ghany. Natural History of Hepatitis C. Gastroenterology Clinics of North America 2015; 44(4): 717 doi: 10.1016/j.gtc.2015.07.003
|
| 100 |
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationship. World Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
|
| 101 |
Javier Ampuero, Manuel Romero-Gomez. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. World Journal of Hepatology 2015; 7(8): 1105-1111 doi: 10.4254/wjh.v7.i8.1105
|
| 102 |
Alaaeldin M.K. Bashier, Dileep Kumar, Fakhriya J. Alalawi, Hind Al Nour, Amna Khalifa Al Hadari, Azza Abdulaziz Bin Hussain. Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges. Dubai Diabetes and Endocrinology Journal 2022; 28(3): 79 doi: 10.1159/000522092
|
| 103 |
H. Y. Choi, Y. Kim, H. Cho, B. H. Kim, M. Ki. Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002‐2013: A population‐based cohort study. Journal of Viral Hepatitis 2018; 25(3): 272 doi: 10.1111/jvh.12815
|
| 104 |
Xuan Guo, Min Jin, Ming Yang, Ke Liu, Jun-wen Li. Type 2 Diabetes Mellitus and the Risk of Hepatitis C Virus Infection: A systematic review. Scientific Reports 2013; 3(1) doi: 10.1038/srep02981
|
| 105 |
Ahmad Nawaz, Javeria Kiran, Amina Zafar, Shahroz Alam, Muhammad Amjad Bashir, Munaza Batool, Sagheer Atta, Mamoona Noreen, Muhammad Yousaf Ali, Khizar Samiullah, Riffat Yasin, Mahroz Fazal, Wadi B. Alonazi, Awais Amjad, Safdar Hussain, Umair Khurshid, Muhammad Essa. A study on causes and community response regarding diabetes as a community disease of southern Punjab Pakistan. Journal of King Saud University - Science 2023; 35(3): 102519 doi: 10.1016/j.jksus.2022.102519
|
| 106 |
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-Analysis. Dubai Diabetes and Endocrinology Journal 2018; 24(1-4): 29 doi: 10.1159/000493945
|
| 107 |
Shih Ping Lin, Chun-Ying Wu, Chang-Bi Wang, Tsai-Chung Li, Nai-Ying Ko, Zhi-Yuan Shi. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy. Medicine 2018; 97(36): e12268 doi: 10.1097/MD.0000000000012268
|
| 108 |
Kathy K. Byrd, Jason M. Mehal, Sarah F. Schillie, Robert C. Holman, Dana Haberling, Trudy Murphy. Chronic Liver Disease-Associated Hospitalizations among Adults with Diabetes, National Inpatient Sample, 2001–2012. Public Health Reports 2015; 130(6): 693 doi: 10.1177/003335491513000619
|
| 109 |
Marco SACCO, Giorgio M. SARACCO. The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C. Minerva Gastroenterology 2021; 67(3) doi: 10.23736/S2724-5985.21.02835-X
|
| 110 |
Dibya L. Praharaj, Anil C. Anand. Nutrition in Viral Hepatitis. Current Hepatology Reports 2023; 22(1): 9 doi: 10.1007/s11901-023-00596-6
|
| 111 |
S.Sukumaran Nair, H.A. Chakkera. Effect of HCV, HIV and Coinfection in Kidney Transplant Recipients: Mate Kidney Analyses: The Role of Diabetes. American Journal of Transplantation 2015; 15(3): 846 doi: 10.1111/ajt.13078
|